Press & Publications

Home > Press & Publications

You will find in this section all the publications and press releases.

Dul, M., Nikolic, T., Stefanidou, M., McAteer, M. A., Williams, P., Mous, J., Roep, B. O., Kochba, E., Levin, Y., Peakman, M., Wong, F. S., Dayan, C. M., Tatovic, D., Coulman, S. A., Birchall, J. C., & EE-ASI Consortium (2019). Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. International journal of pharmaceutics, 562, 303–312.

Arikat, F., Hanna, S. J., Singh, R. K., Vilela, L., Wong, F. S., Dayan, C. M., Coulman, S. A., & Birchall, J. C. (2020). Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes. Journal of controlled release : official journal of the Controlled Release Society, 322, 593–601.

Singh, R. K., Malosse, C., Davies, J., Malissen, B., Kochba, E., Levin, Y., Birchall, J. C., Coulman, S. A., Mous, J., McAteer, M. A., Dayan, C. M., Henri, S., & Wong, F. S. (2021). Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides. Nanomedicine : nanotechnology, biology, and medicine, 32, 102321.

D Tatovic, M A McAteer, J Barry, A Barrientos, K Rodríguez Terradillos, I Perera, E Kochba, Y Levin, M Dul, S A Coulman, J C Birchall, C von Ruhland, A Howell, R Stenson, M Alhadj Ali, S D Luzio, G Dunseath, W Y Cheung, G Holland, K May, J R Ingram, M M U Chowdhury, F S Wong, R Casas, C Dayan, J Ludvigsson, Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes, Immunotherapy Advances, Volume 2, Issue 1, 2022, ltac002

Zhao X, Coulman SA, Hanna SJ, Susan Wong F, Dayan CM, Birchall JC. Formulation of hydrophobic peptides for skin delivery via coated microneedles. J Control Release. 2017 March 9.

Dul M, Stefanidou M, Porta P, Serve J, O'Mahony C, Malissen B, Henri S, Levin Y, Kochba E, Wong FS, Dayan C, Coulman SA, Birchall JC. Hydrodynamic gene delivery in human skin using a hollow microneedle device. J Control Release. 2017 Feb 28.

Zhao X, Birchall JC, Coulman SA, Tatovic D, Singh RK, Wen L, Susan Wong F, Dayan CM, Hanna SJ. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes. J Control Release. 2016 Feb 10.

Publication of an article on Horizon, the EU Research and Innovation Magazine: "Retraining the immune system may hold key to diabetes prevention". 2016 Jan 13.

Ali MA, Thrower SL, Hanna SJ, Coulman SA, Birchall JC, Wong FS, Dayan CM, Tatovic D. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology. 2015 Nov.

Skowera, A., K. Ladell, J. E. McLaren, G. Dolton, K. K. Matthews, E. Gostick, D. Kronenberg-Versteeg, M. Eichmann, R. R. Knight, S. Heck, J. Powrie, P. J. Bingley, C. M. Dayan, J. J. Miles, A. K. Sewell, D. A. Price, and M. Peakman. 2014. beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes.

Knight, R. R., G. Dolton, D. Kronenberg-Versteeg, M. Eichmann, M. Zhao, G. C. Huang, K. Beck, D. K. Cole, A. K. Sewell, A. Skowera, and M. Peakman. 2014. A distinct immunogenic region of GAD65 is naturally processed and presented by human islet cells to cytotoxic CD8 T-cells. Clin Exp Immunol.

von Herrath M, Peakman M and Roep B. Progress in immune-based therapies for type 1 diabetes. Clinical and Experimental Immunology. Jan 2013, 178-85